Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Centogene N.V. (CNTG)

Centogene N.V. (CNTG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Centogene N.V. AM STRANDE 7 ROSTOCK 2M 18055 DEU

www.centogene.com P: 818-011-3500

Description:

Centogene is a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The Company's goal is to bring rationality to treatment decisions and to accelerate the development of new orphan drugs by using their knowledge of the global rare disease market, including epidemiological and clinical data and innovative biomarkers.

Key Statistics

Overview:

Market Capitalization, $K 8,801
Enterprise Value, $K 59,461
Shares Outstanding, K 27,080
Annual Sales, $ 52,700 K
Annual Net Income, $ -38,580 K
Last Quarter Sales, $ 11,920 K
Last Quarter Net Income, $ -11,010 K
EBIT, $ -62,880 K
EBITDA, $ -54,620 K
60-Month Beta -0.67
% of Insider Shareholders 1.93%
% of Institutional Shareholders 9.94%
Float, K 26,557
% Float 98.07%
Short Volume Ratio 0.77

Growth:

1-Year Return -67.50%
3-Year Return -97.16%
5-Year Return 0.00%
5-Year Revenue Growth 10.25%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/21/24
Earnings Per Share ttm -2.67
EPS Growth vs. Prev Year 213.24%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CNTG Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -73.21%
Debt/Equity -2.60
Price/Sales 0.19
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.01
Interest Coverage -3.19
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar